Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Novacyt S.A. (CDI) (NCYT)

Sector:

Health Care

Index:

FTSE AIM All-Share

76.00p

Change Today:

-0.50p
52 Week High: 246.90
52 Week Low: 59.40

Currency: UK Pounds
Shares Issued: 70.63m
Volume: 46,465

Market Cap: £53.68m
RiskGrade: 453

NCYT Overview

The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.

1 Day Chart

6 Month Chart

More Novacyt S.A. (CDI) charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	-8.1%	42.0%
ROCE	n/a

	Latest	F'cast
P/E	n/a	1.9
PEG	n/a	n/a
Pr/Revenue	55.9	0.7
Pr/Book	0.4

	Latest	F'cast
Revenue	-99.7%	-3.8%
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

NCYT Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-17	12.75	(3.49)	(15.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-18	13.72	(2.08)	(6.00)¢	n/a	n/a	n/a	n/a	0.0%
31-Dec-19	11.47	(3.43)	(8.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-20	277.20	165.17	194.00p	4.4	n/a	n/a	n/a	0.0%
31-Dec-21	95.78	(9.83)	(0.14)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

NCYT Forecasts

Year Ending	Revenue ( m)	Pre-tax ( m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-22	81.00	34.00	40.00¢	2.2	n/a	n/a	n/a	0.0%
31-Dec-23	55.00	20.00	23.00¢	3.8	n/a	-42%	n/a	0.0%
31-Dec-24	81.00	22.00	25.00¢	3.5	0.4	+9%	n/a	0.0%

Novacyt S.A. (CDI) forecasts

NCYT Company Announcements

Full Year 2022 Trading Update	26-Jan-2023	07:00	RNS
Holdings in Company	06-Jan-2023	12:15	RNS
Liquidity Agreement and Total Voting Rights	03-Jan-2023	12:30	RNS

More Novacyt S.A. (CDI) ncyt company announcements

NCYT ShareCast News

UK regulator approves Novacyt Covid-19 test	06-Dec-2022	ShareCast
Novacyt's exsig Covid-19 PCR test receives UK ap...	15-Jul-2022	ShareCast
Novacyt gets another Covid-19 test approved in t...	17-Feb-2022	ShareCast

More Novacyt S.A. (CDI) ShareCast news

Latest NCYT Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

NCYT Market Data

Currency	UK Pounds
Share Price	76.00p
Change Today	-0.50p
% Change	-0.65 %
52 Week High	246.90
52 Week Low	59.40
Volume	46,465
Shares Issued	70.63m
Market Cap	£53.68m
RiskGrade	453